Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization.
The Optima HIV brand was launched in 2012 but precursors to the model were in development from 2004. Since the Optima launch in 2012, the model has been applied worldwide. Findings from Optima HIV applications and studies have been used to inform: the United Nations General Assembly, Global Fund to Fight AIDS, Tuberculosis and Malaria, Association of Southeast Asian Nations, national HIV/AIDS Strategic Plans, national Global Fund Concept Note applications, and country reports.
Optima HIV results can be used to improve country and health policy decision-making by informing domestic and donor public health funding allocations towards better achieving HIV targets.
The Optima HIV software was conceptualised and developed by the Optima Consortium for Decision Science with technical input from the World Bank, and is owned by Optima Consortium for Decision Science, Ltd. Optima HIV can be reached through www.hiv.optimamodel.com and is free and open source, with the code available for download on GitHub.
Optima HIV helps to:
To access the Optima HIV open source model, click here.
Access the user guide and training materials here.
The primary Consortium partners for developing and applying the Optima suite of tools are University College London, University of Bern, and the University of New South Wales.
Optima tools have been developed and applied in close partnership and with funding from global health agencies including the: World Bank, Global Fund, and the U.S. Centers for Disease Control. Optima also receives funding from the Australian National Health and Medical Research Council.
The Optima HIV tool is part of the HIV Modelling Consortium, a group supporting evidence-informed decision making by facilitating the application of multiple mathematical models in sub-Saharan Africa.
REPORTS
2004 – ongoing
University College London University of Bern University of New South Wales
World Bank, Global Fund to Fight AIDS, Tuberculosis and Malaria, U.S. Centers for Disease Control, Australian National Health and Medical Research Council
For any general enquiries relating to this project, please contact:
Head, Modelling & Biostatistics